Skip to content

Triglycerides 20767107322

by Roche Diagnostics GmbH

Triglycerides 20767107322 is a triglyceride IVD (FDA Class I; FDA product code CDT, Lipase Hydrolysis/Glycerol Kinase Enzyme, Triglycerides) made by Roche Diagnostics GmbH, cleared under FDA 510(k) K873049 on 28 Aug 1987 and listed in FDA GUDID since 8 Feb 2021 (UDI-DI 04015630918393), active as of 12 Nov 2026. One FDA recall is linked to it.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

2 closed

Documents

510(k) K873049

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 12 Nov 2026.

Regulatory status

as of registry sync 12 Nov 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number04015630918393 UDI-DI Date8 Feb 2021ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK873049 Date28 Aug 1987DecidedStatusActive

Official records

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 12 Nov 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K873049 decided 28 Aug 1987 Active
  • FDA GUDID UDI-DI 04015630918393 listed 8 Feb 2021 Listed

Recalls

2 recalls · FDA

    • Terminated Z-1125-2019 FDA Class II initiated 14 Dec 2018 on shared 510(k) K873049

    COBAS INTEGRA 400 plus and cobas c 111 analyzers Additional Extra Wash Cycle Configurations and/or Batch Mode Needed for Specific Tests Due to Carry-over

    • Terminated Z-1930-2015 FDA Class II initiated 7 May 2015

    Possible drug interference when using the Trinder reaction method on multiple Cobas Analyzers. Results of Trinder tests may be falsely decreased when the tests are run with urine samples (Creatinine plus and Uric Acid applications only) or blood samples collected before sufficient time has lapsed after the administration of the drugs Acetaminophen and N-acetylcysteine.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Timeline

4 dated events

  1. Cleared FDA 510(k) K873049
  2. Recall initiated FDA recalls Z-1930-2015
  3. Recall initiated FDA recalls Z-1125-2019
  4. Listed FDA GUDID 04015630918393

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Triglycerides
Generic name
Triglyceride IVD, kit, spectrophotometry
Model / Ref / Catalog
20767107322
Primary DI / UDI-DI
04015630918393
510(k) Number
FDA product code
CDT
GMDN term
Triglyceride IVD, kit, spectrophotometry
Device class
Class I
Regulation number
862.1705
GUDID distribution status
In Commercial Distribution

Other devices from Roche Diagnostics GmbH

See all devices from Roche Diagnostics GmbH →

Properties

  • Single use
  • Prescription use
  • Lot / batch number
  • Expiration date
Other properties (11, all answered No)